<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xsi:schemaLocation="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2022v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-11-15T19:27:09-06:00</ReturnTs>
    <TaxPeriodEndDt>2022-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3333 New Hyde Park Rd Ste 406</AddressLine1Txt>
        <CityNm>New Hyde Park</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>11042</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2022-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>814172003</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Lytton-Kambara Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% Foundation Source</InCareOfNm>
      <BusinessNameControlTxt>LYTT</BusinessNameControlTxt>
      <PhoneNum>8008391754</PhoneNum>
      <USAddress>
        <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
        <CityNm>Wilmington</CityNm>
        <StateAbbreviationCd>DE</StateAbbreviationCd>
        <ZIPCd>198091377</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Laurence Lytton</PersonNm>
      <PersonTitleTxt>PRESIDENT</PersonTitleTxt>
      <PhoneNum>8008391754</PhoneNum>
      <SignatureDt>2023-11-14</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>Laurence</PersonFirstNm>
        <PersonLastNm>Lytton</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>Jeffrey D Haskell</PreparerPersonNm>
      <PTIN>P01345770</PTIN>
      <PhoneNum>8008391754</PhoneNum>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp />
    </AdditionalFilerInformation>
    <TaxYr>2022</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="12">
    <IRS990PF documentId="IRS990PF">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>31601872</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>545844</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>152570</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>152570</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>115625</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>115625</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>1110124</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>24415558</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>1608351</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="OtherIncomeSch2">182223</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>182223</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>2106386</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>2058769</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="OthProfFeesSch">530</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>530</OtherProfFeesNetInvstIncmAmt>
        <InterestRevAndExpnssAmt>85</InterestRevAndExpnssAmt>
        <InterestNetInvstIncmAmt>85</InterestNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="TaxesSchedule">57477</TaxesRevAndExpnssAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="OtherExpensesSch">121080</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>14830</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>106250</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>179172</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>15445</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>106250</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>1478900</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>1478900</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>1658072</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>15445</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>1585150</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>448314</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>2043324</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <SavAndTempCashInvstBOYAmt>150324</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>12391572</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>12391572</SavAndTempCashInvstEOYFMVAmt>
        <AcctRcvblAmt>1267</AcctRcvblAmt>
        <AcctRcvblEOYAmt>1267</AcctRcvblEOYAmt>
        <AcctRcvblEOYFMVAmt>1267</AcctRcvblEOYFMVAmt>
        <OtherNtsAndLoansRcvblAmt>4000417</OtherNtsAndLoansRcvblAmt>
        <OtherNtsAndLoansRcvblBOYAmt>4000000</OtherNtsAndLoansRcvblBOYAmt>
        <OtherNtsAndLoansRcvblEOYAmt referenceDocumentId="OthNoteLoanRcvblLong">4000417</OtherNtsAndLoansRcvblEOYAmt>
        <OtherNtsAndLoansRcvblEOYFMVAmt>3000417</OtherNtsAndLoansRcvblEOYFMVAmt>
        <CorporateStockBOYAmt>26767120</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="InvestCorpStockSch">18819415</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>12266789</CorporateStockEOYFMVAmt>
        <CorporateBondsBOYAmt>3240000</CorporateBondsBOYAmt>
        <CorporateBondsEOYAmt referenceDocumentId="InvestCorpBondsSch">979005</CorporateBondsEOYAmt>
        <CorporateBondsEOYFMVAmt>1287927</CorporateBondsEOYFMVAmt>
        <OtherInvestmentsBOYAmt>5575962</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="InvOtherSch2">5591925</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>2653900</OtherInvestmentsEOYFMVAmt>
        <TotalAssetsBOYAmt>39733406</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>41783601</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>31601872</TotalAssetsEOYFMVAmt>
        <OtherLiabilitiesEOYAmt referenceDocumentId="OtherLiabSch">1601881</OtherLiabilitiesEOYAmt>
        <TotalLiabilitiesBOYAmt>0</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>1601881</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <RetainedEarningBOYAmt>39733406</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>40181720</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>39733406</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>40181720</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>39733406</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>41783601</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>39733406</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>448314</ExcessRevenueOverExpensesAmt>
        <SubtotalAmt>40181720</SubtotalAmt>
        <TotNetAstOrFundBalancesEOYAmt>40181720</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>Publicly-traded Securities</PropertyDesc>
          <GrossSalesPriceAmt>24164457</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22215166</CostOrOtherBasisAmt>
          <GainOrLossAmt>1949291</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1949291</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-14</SoldDt>
          <GrossSalesPriceAmt>10993</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>20400</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9407</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9407</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-19</SoldDt>
          <GrossSalesPriceAmt>5492</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10585</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5093</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5093</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>2707</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2960</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2960</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>2797</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2870</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2870</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>3807</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7933</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4126</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4126</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>2700</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2967</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2967</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>2755</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2912</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2912</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-20</SoldDt>
          <GrossSalesPriceAmt>6504</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>13600</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7096</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7096</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-22</SoldDt>
          <GrossSalesPriceAmt>2465</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3202</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3202</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-22</SoldDt>
          <GrossSalesPriceAmt>4038</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9067</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5029</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5029</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-25</SoldDt>
          <GrossSalesPriceAmt>2360</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3307</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3307</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-25</SoldDt>
          <GrossSalesPriceAmt>2784</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6800</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4016</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4016</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-27</SoldDt>
          <GrossSalesPriceAmt>1831</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2702</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2702</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-27</SoldDt>
          <GrossSalesPriceAmt>2287</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3380</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3380</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-27</SoldDt>
          <GrossSalesPriceAmt>9830</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>24582</CostOrOtherBasisAmt>
          <GainOrLossAmt>-14752</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-14752</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-04-29</SoldDt>
          <GrossSalesPriceAmt>4611</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>13600</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8989</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8989</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-02</SoldDt>
          <GrossSalesPriceAmt>25035</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>78280</CostOrOtherBasisAmt>
          <GainOrLossAmt>-53245</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-53245</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-02</SoldDt>
          <GrossSalesPriceAmt>11036</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>33989</CostOrOtherBasisAmt>
          <GainOrLossAmt>-22953</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-22953</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>1676</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3991</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3991</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>3449</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11334</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7885</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7885</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>3300</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11651</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8351</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8351</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>1675</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3992</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3992</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>3390</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11300</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7910</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7910</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-05-04</SoldDt>
          <GrossSalesPriceAmt>3210</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11334</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8124</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8124</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-06-17</SoldDt>
          <GrossSalesPriceAmt>5360</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-17307</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-17307</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-11-09</SoldDt>
          <GrossSalesPriceAmt>9158</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>21534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-12376</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-12376</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-11-10</SoldDt>
          <GrossSalesPriceAmt>7967</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17601</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9634</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9634</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-07</SoldDt>
          <GrossSalesPriceAmt>16648</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>28583</CostOrOtherBasisAmt>
          <GainOrLossAmt>-11935</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-11935</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-12</SoldDt>
          <GrossSalesPriceAmt>1670</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3128</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1458</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1458</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-12</SoldDt>
          <GrossSalesPriceAmt>4485</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8273</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3788</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3788</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-12</SoldDt>
          <GrossSalesPriceAmt>6658</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12467</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5809</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5809</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-14</SoldDt>
          <GrossSalesPriceAmt>3887</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6403</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2516</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2516</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-14</SoldDt>
          <GrossSalesPriceAmt>4800</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8228</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3428</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3428</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-14</SoldDt>
          <GrossSalesPriceAmt>675</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1133</CostOrOtherBasisAmt>
          <GainOrLossAmt>-458</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-458</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-14</SoldDt>
          <GrossSalesPriceAmt>3655</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6279</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2624</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2624</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-16</SoldDt>
          <GrossSalesPriceAmt>1120</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2267</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1147</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1147</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-16</SoldDt>
          <GrossSalesPriceAmt>3027</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2640</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2640</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-16</SoldDt>
          <GrossSalesPriceAmt>4295</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7934</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3639</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3639</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-19</SoldDt>
          <GrossSalesPriceAmt>23243</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>50660</CostOrOtherBasisAmt>
          <GainOrLossAmt>-27417</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-27417</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-28</SoldDt>
          <GrossSalesPriceAmt>9478</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>20809</CostOrOtherBasisAmt>
          <GainOrLossAmt>-11331</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-11331</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-29</SoldDt>
          <GrossSalesPriceAmt>4006</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7934</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3928</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3928</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-29</SoldDt>
          <GrossSalesPriceAmt>4013</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7933</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3920</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3920</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-29</SoldDt>
          <GrossSalesPriceAmt>10672</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>21216</CostOrOtherBasisAmt>
          <GainOrLossAmt>-10544</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-10544</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-30</SoldDt>
          <GrossSalesPriceAmt>2756</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2911</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2911</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2022-12-30</SoldDt>
          <GrossSalesPriceAmt>2796</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2871</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2871</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>1608351</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>28402</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>28402</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>28402</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>3300</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>56500</ExtsnRequestIncomeTaxPaidAmt>
        <TotalPaymentsAndCreditsAmt>59800</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="IRS2220">X</Form2220AttachedInd>
        <EsPenaltyAmt>668</EsPenaltyAmt>
        <OverpaymentAmt>30730</OverpaymentAmt>
        <AppliedToESTaxAmt>30730</AppliedToESTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>DE</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <PersonsWithBooksName>
          <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
        </PersonsWithBooksName>
        <PhoneNum>8008391754</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>501 Silverside Road Suite 123</AddressLine1Txt>
          <CityNm>Wilmington</CityNm>
          <StateAbbreviationCd>DE</StateAbbreviationCd>
          <ZIPCd>198091377</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>false</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Janice Kambara</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Katherine Lytton</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Laurence Lytton</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir, Pres, Sec, Treas</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>8.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>55 Walls Drive 3rd Fl</AddressLine1Txt>
            <CityNm>Fairfield</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06824</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>Administrative</ServiceTypeTxt>
          <CompensationAmt>106225</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SummaryOfDirectChrtblActyGrp />
      <SumOfProgramRelatedInvstGrp />
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>18145505</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>9160895</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>5797530</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>33103930</TotalFMVOfUnusedAssetsAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>33103930</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>496559</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>32607371</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>1630369</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>1630369</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>28402</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>28402</TotalTaxAmt>
        <DistributableBeforeAdjAmt>1601967</DistributableBeforeAdjAmt>
        <DistributableBeforeDedAmt>1601967</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>1601967</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>1585150</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <CharitableAssetsAcquisPaidAmt>0</CharitableAssetsAcquisPaidAmt>
        <SetAsideSuitabilityTestAmt>0</SetAsideSuitabilityTestAmt>
        <SetAsideCashDistriTestAmt>0</SetAsideCashDistriTestAmt>
        <QualifyingDistributionsAmt>1585150</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>1601967</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>1565305</UndistributedIncomePYAmt>
        <PriorYear1Yr>2020</PriorYear1Yr>
        <PriorYear2Yr>2019</PriorYear2Yr>
        <PriorYear3Yr>2018</PriorYear3Yr>
        <QualifyingDistributionsAmt>1585150</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>1565305</AppliedToYear1Amt>
        <AppliedToCurrentYearAmt>19845</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>0</RemainingDistriFromCorpusAmt>
        <TotalCorpusAmt>0</TotalCorpusAmt>
        <UndistributedIncomeCYAmt>1582122</UndistributedIncomeCYAmt>
        <ExcessDistriCyovToNextYrAmt>0</ExcessDistriCyovToNextYrAmt>
        <ExcessFromCurrentYearAmt>0</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <PrivateOperatingFoundationsGrp></PrivateOperatingFoundationsGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>Janice Kambara</ContributingManagerNm>
        <ContributingManagerNm>Laurence Lytton</ContributingManagerNm>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOWDOIN COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4100 COLLEGE STA</AddressLine1Txt>
            <CityNm>BRUNSWICK</CityNm>
            <StateAbbreviationCd>ME</StateAbbreviationCd>
            <ZIPCd>04011</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Clare McWilliams Lyne Scholarship Fund</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRYN MAWR COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>101 N MERION AVE</AddressLine1Txt>
            <CityNm>BRYN MAWR</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19010</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Bryn Mawr Scholarship Fund</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTRAL PARK CONSERVANCY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>717 FIFTH AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ETHICAL CULTURE FIELDSTON SCHOOL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 CENTRAL PARK W</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10023</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GARDINER LIBRARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 223</AddressLine1Txt>
            <CityNm>GARDINER</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HUDSON VALLEY RAIL TRAIL ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>TOWN HALL - 12 CHURCH ST</AddressLine1Txt>
            <CityNm>HIGHLAND</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12528</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KHAN ACADEMY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 1630</AddressLine1Txt>
            <CityNm>MOUNTAIN VIEW</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94042</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>1000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MOHONK PRESERVE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3197 RTE 44 55</AddressLine1Txt>
            <CityNm>GARDINER</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>2500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURAL RESOURCES DEFENSE COUNCIL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>40 WEST 20TH ST 11TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10011</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK PUBLIC RADIO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>160 VARICK ST</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK-NEW JERSEY TRAIL CONFERENCE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 RAMAPO VALLEY RD</AddressLine1Txt>
            <CityNm>MAHWAH</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07430</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTHWELL HEALTH FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2000 MARCUS AVE 2ND FL</AddressLine1Txt>
            <CityNm>NEW HYDE PARK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11042</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Lenox Hill Hospital Research Laboratory of Dr. Richard L. Whelan fund</GrantOrContributionPurposeTxt>
          <Amt>1500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OPEN SPACE INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1350 BROADWAY RM 201</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TO SUPPORT THE ON-GOING WORK OF OSI ON THE SHAWANGUNK RIDGE</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARKS &amp; TRAILS NEW YORK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 ELK ST</AddressLine1Txt>
            <CityNm>ALBANY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12207</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>300</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRO PUBLICA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>155 AVE OF THE AMERICAS 13TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RIVERKEEPER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>20 SECOR RD</AddressLine1Txt>
            <CityNm>OSSINING</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10562</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE FRIENDS OF THE GLOVERSVILLE PUBLIC LIBRARY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>58 E FULTON ST</AddressLine1Txt>
            <CityNm>GLOVERSVILLE</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12078</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUST FOR PUBLIC LAND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>666 BROADWAY 9TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10012</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>310000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WIKIMEDIA FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 98204</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20090</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>1478900</TotalGrantOrContriPdDurYrAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <FeesContractsFromGovtAgGrp />
        <MembershipDuesAndAssmntGrp />
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>152570</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>115625</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <NetRntlIncmReDebtFincdPropGrp />
        <NetRntlIncmReNotDebtFincdProp />
        <NetRentalIncomePersonalPropGrp />
        <OtherInvestmentIncomeGrp />
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>1110124</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <NetIncomeLossFromSpecialEvtGrp />
        <GrossProfitLossSlsOfInvntryGrp />
        <OtherRevenueDescribedGrp>
          <Desc>INTEREST INCOME FROM NOTES</Desc>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>182223</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>1560542</ExclusionAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>1560542</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="IRS990ScheduleB">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorPersonNm>Isabel Lytton 2014 Trust</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 CENTRAL PARK WEST 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>118051</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorPersonNm>Kate Lytton 2014 Trust</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 CENTRAL PARK WEST 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>140292</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>3</ContributorNum>
        <ContributorPersonNm>William Lytton Trust</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 CENTRAL PARK WEST 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>287500</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>Verttex Energy, Inc VTNR, 12208 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>118051</FairMarketValueAmt>
        <ReceivedDt>2022-03-31</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>2</ContributorNum>
        <NoncashPropertyDesc>Verttex Energy, Inc VTNR, 14508 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>140292</FairMarketValueAmt>
        <ReceivedDt>2022-03-31</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>3</ContributorNum>
        <NoncashPropertyDesc>Apollo Endosurgery APEN, 50000 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>287500</FairMarketValueAmt>
        <ReceivedDt>2022-09-16</ReceivedDt>
      </NonCashPropertyContributionGrp>
    </IRS990ScheduleB>
    <DepreciationSchedule documentId="DepreciationSch" />
    <InvestmentsCorpBondsSchedule documentId="InvestCorpBondsSch">
      <InvestmentsCorporateBondsGrp>
        <BondNm>PARATEK PHARMACEUTICALS INC -</BondNm>
        <EOYBookValueAmt>349005</EOYBookValueAmt>
        <EOYFMVAmt>347680</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
      <InvestmentsCorporateBondsGrp>
        <BondNm>VERTEX ENERGY INC BOND - 6.250</BondNm>
        <EOYBookValueAmt>630000</EOYBookValueAmt>
        <EOYFMVAmt>940247</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
    </InvestmentsCorpBondsSchedule>
    <InvestmentsCorpStockSchedule documentId="InvestCorpStockSch">
      <InvestmentsCorporateStockGrp>
        <StockNm>ALBIREO PHARMA INC</StockNm>
        <EOYBookValueAmt>1073548</EOYBookValueAmt>
        <EOYFMVAmt>1093120</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALDEYRA THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>252047</EOYBookValueAmt>
        <EOYFMVAmt>475702</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALIGOS THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>5744</EOYBookValueAmt>
        <EOYFMVAmt>4926</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALPINE IMMUNE SCIENCES</StockNm>
        <EOYBookValueAmt>602072</EOYBookValueAmt>
        <EOYFMVAmt>869498</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ATYR PHARMA INC COM NEW</StockNm>
        <EOYBookValueAmt>979311</EOYBookValueAmt>
        <EOYFMVAmt>269271</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BEYOND AIR</StockNm>
        <EOYBookValueAmt>5001</EOYBookValueAmt>
        <EOYFMVAmt>5601</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BIONOMICS</StockNm>
        <EOYBookValueAmt>42490</EOYBookValueAmt>
        <EOYFMVAmt>18135</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CALL - XFOR @ 2 02/17/2023</StockNm>
        <EOYBookValueAmt>616</EOYBookValueAmt>
        <EOYFMVAmt>118</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES COMMON W</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES PRE FUND</StockNm>
        <EOYBookValueAmt>740661</EOYBookValueAmt>
        <EOYFMVAmt>607452</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CLEARPOINT NEURO INC</StockNm>
        <EOYBookValueAmt>87558</EOYBookValueAmt>
        <EOYFMVAmt>77077</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>COHU INC</StockNm>
        <EOYBookValueAmt>371505</EOYBookValueAmt>
        <EOYFMVAmt>410240</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CONFORMIS INC</StockNm>
        <EOYBookValueAmt>35452</EOYBookValueAmt>
        <EOYFMVAmt>7968</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DIAMEDICA THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>1246881</EOYBookValueAmt>
        <EOYFMVAmt>502570</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DUOS TECHNOLOGIES GROUP INC</StockNm>
        <EOYBookValueAmt>1005000</EOYBookValueAmt>
        <EOYFMVAmt>670000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ELECTROVAYA CMN WTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ELECTROVAYA INC</StockNm>
        <EOYBookValueAmt>1199999</EOYBookValueAmt>
        <EOYFMVAmt>1430496</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ELEDON PHARMACEUTICALS ORD SHS</StockNm>
        <EOYBookValueAmt>48922</EOYBookValueAmt>
        <EOYFMVAmt>25992</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EMCORE CORPORATION</StockNm>
        <EOYBookValueAmt>1411399</EOYBookValueAmt>
        <EOYFMVAmt>612945</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EXAGEN INC COM</StockNm>
        <EOYBookValueAmt>23895</EOYBookValueAmt>
        <EOYFMVAmt>6288</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>GIGA-TRONICS INC - WARRANT</StockNm>
        <EOYBookValueAmt>749999</EOYBookValueAmt>
        <EOYFMVAmt>156923</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>LAKELAND INDUSTRIES, INC.</StockNm>
        <EOYBookValueAmt>45510</EOYBookValueAmt>
        <EOYFMVAmt>32159</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>LIQTECH INTERNATIONAL INC</StockNm>
        <EOYBookValueAmt>2101051</EOYBookValueAmt>
        <EOYFMVAmt>151522</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MIROMATRIX MED INC</StockNm>
        <EOYBookValueAmt>361791</EOYBookValueAmt>
        <EOYFMVAmt>120195</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NUVVE HOLDING CORP WARRANTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NYXOAH ORD SHS</StockNm>
        <EOYBookValueAmt>2977</EOYBookValueAmt>
        <EOYFMVAmt>2445</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OMNIQ CORP COMMON</StockNm>
        <EOYBookValueAmt>210931</EOYBookValueAmt>
        <EOYFMVAmt>131380</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ORYZON GENOMICS</StockNm>
        <EOYBookValueAmt>32119</EOYBookValueAmt>
        <EOYFMVAmt>22498</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PERFORMANT FINANCIAL</StockNm>
        <EOYBookValueAmt>147336</EOYBookValueAmt>
        <EOYFMVAmt>136458</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PLUG POWER INC</StockNm>
        <EOYBookValueAmt>1465</EOYBookValueAmt>
        <EOYFMVAmt>6185</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>QUICKLOGIC</StockNm>
        <EOYBookValueAmt>1510180</EOYBookValueAmt>
        <EOYFMVAmt>1182200</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>RENEO PHARMACEUTICALS ORD SHS</StockNm>
        <EOYBookValueAmt>42757</EOYBookValueAmt>
        <EOYFMVAmt>15921</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>REPRO MEDSYSTEMS INC</StockNm>
        <EOYBookValueAmt>53175</EOYBookValueAmt>
        <EOYFMVAmt>63885</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES</StockNm>
        <EOYBookValueAmt>400004</EOYBookValueAmt>
        <EOYFMVAmt>400004</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES, INC - C</StockNm>
        <EOYBookValueAmt>902776</EOYBookValueAmt>
        <EOYFMVAmt>1045319</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES, INC - W</StockNm>
        <EOYFMVAmt>92000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SEELOS THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>8100</EOYBookValueAmt>
        <EOYFMVAmt>3400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SPECTRA7 MICROSYSTEMS INC</StockNm>
        <EOYBookValueAmt>2006400</EOYBookValueAmt>
        <EOYFMVAmt>568670</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>UROGEN PHARMA LTD</StockNm>
        <EOYBookValueAmt>529723</EOYBookValueAmt>
        <EOYFMVAmt>521804</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VERRICA PHARMACEUTICALS INC</StockNm>
        <EOYBookValueAmt>5495</EOYBookValueAmt>
        <EOYFMVAmt>5308</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>X4 PHARMACEUTICALS</StockNm>
        <EOYBookValueAmt>575525</EOYBookValueAmt>
        <EOYFMVAmt>521114</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsOtherSchedule2 documentId="InvOtherSch2">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LIFESCI VENTURE SPV XIII LLC</CategoryOrItemTxt>
        <BookValueAmt>1214664</BookValueAmt>
        <EOYFMVAmt>1214663</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LIQTECH INTL INC - (PRE-FUNDED</CategoryOrItemTxt>
        <BookValueAmt>2969301</BookValueAmt>
        <EOYFMVAmt>233700</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MAXONA PHARMACEUTICALS, INC. P</CategoryOrItemTxt>
        <BookValueAmt>1000000</BookValueAmt>
        <EOYFMVAmt>1000000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>OMEGA THERAPEUTICS, INC PFD SE</CategoryOrItemTxt>
        <BookValueAmt>407960</BookValueAmt>
        <EOYFMVAmt>205537</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <OtherExpensesSchedule documentId="OtherExpensesSch">
      <OtherExpensesScheduleGrp>
        <Desc>Administrative Fees</Desc>
        <RevenueAndExpensesPerBooksAmt>106225</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>106225</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Bank Charges</Desc>
        <RevenueAndExpensesPerBooksAmt>2382</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>2382</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>K-1 Exp LIFESCI VENTURE SPV XI</Desc>
        <RevenueAndExpensesPerBooksAmt>12448</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>12448</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>State or Local Filing Fees</Desc>
        <RevenueAndExpensesPerBooksAmt>25</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>25</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="OtherIncomeSch2">
      <OtherIncomeDetail>
        <Desc>Interest Income from Notes</Desc>
        <RevenueAndExpensesPerBooksAmt>182223</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>182223</NetInvestmentIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherLiabilitiesSchedule documentId="OtherLiabSch">
      <OtherLiabilitiesDetail>
        <Desc>SHORT SALES OF APEN</Desc>
        <EOYBookValueAmt>1601881</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
    </OtherLiabilitiesSchedule>
    <OtherNotesLoansRcvblLongSch documentId="OthNoteLoanRcvblLong">
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SPECTRA7 MICROSYSTEMS INC</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>2000417</LoanOriginalAmt>
        <BalanceDueAmt>2000417</BalanceDueAmt>
        <NoteDt>2022-07</NoteDt>
        <LoanMaturityDt>2024-12</LoanMaturityDt>
        <RepaymentTermsTxt>INT/PRIN DUE SEMI-ANNU&amp;ON MATURITY</RepaymentTermsTxt>
        <InterestRt>14.</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>CYREN LTD</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>1000000</LoanOriginalAmt>
        <BalanceDueAmt>1000000</BalanceDueAmt>
        <NoteDt>2020-03</NoteDt>
        <LoanMaturityDt>2024-03</LoanMaturityDt>
        <RepaymentTermsTxt>INT/PRIN DUE SEMI-ANNU&amp;ON MATURITY</RepaymentTermsTxt>
        <InterestRt>5.75</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>CIRCULOGENE THERANOSTICS INC</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>1000000</LoanOriginalAmt>
        <BalanceDueAmt>1000000</BalanceDueAmt>
        <NoteDt>2021-03</NoteDt>
        <LoanMaturityDt>2025-04</LoanMaturityDt>
        <RepaymentTermsTxt>INT&amp;PRIN DUE ANNUALLY&amp;ON MATURITY</RepaymentTermsTxt>
        <InterestRt>5.</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
    </OtherNotesLoansRcvblLongSch>
    <OtherProfessionalFeesSchedule documentId="OthProfFeesSch">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Investment Management Services</CategoryTxt>
        <Amt>530</Amt>
        <NetInvestmentIncomeAmt>530</NetInvestmentIncomeAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="TaxesSchedule">
      <TaxesDetail>
        <CategoryTxt>990-PF Estimated Tax for 2022</CategoryTxt>
        <Amt>3300</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>990-PF Excise Tax for 2021</CategoryTxt>
        <Amt>42477</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>990-PF Extension for 2021</CategoryTxt>
        <Amt>11700</Amt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>
